Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

136.87
+0.81000.60%
Post-market: 136.870.00000.00%16:15 EST
Volume:1.32M
Turnover:180.74M
Market Cap:264.96B
PE:18.75
High:137.27
Open:136.48
Low:136.00
Close:136.06
52wk High:137.40
52wk Low:96.06
Shares:1.94B
Float Shares:1.84B
Volume Ratio:0.75
T/O Rate:0.07%
Dividend:3.86
Dividend Rate:2.82%
EPS(TTM):7.30
EPS(LYR):5.92
ROE:32.62%
ROA:12.13%
PB:5.98
PE(LYR):23.13

Loading ...

Novartis to launch direct-to-patient platform for Cosentyx in U.S.

TIPRANKS
·
Sep 29

European Equities Close Higher in Friday Trading; Eurozone Consumer Inflation Expectations Rise

MT Newswires Live
·
Sep 27

Amneal Pharmaceuticals Files Biologics License Application for Xolair Biosimilar

MT Newswires Live
·
Sep 26

Novartis Says Won't be Impacted by 100% Tariff on Branded Pharmaceutical Products

MT Newswires Live
·
Sep 26

U.S. Tariffs Pose Limited Risk to Big Swiss Pharma Groups -- Market Talk

Dow Jones
·
Sep 26

Novartis AG (NVS.US) CD20-Targeting Therapy Maintains High Efficacy for Up to 7 Years with Patient Self-Injection Option

Stock News
·
Sep 26

Eli Lilly Stock Is Trading Down Thursday: What's Behind The Move?

Benzinga_recent_news
·
Sep 26

Novartis increased its stockpiles of pharmaceuticals in the U.S., Reuters says

TIPRANKS
·
Sep 22

Novartis looking into price cut proposals for U.S., Bloomberg reports

TIPRANKS
·
Sep 22

Novartis AG CEO Says Company Studying Price Reduction Plans for US Market, Maintains Revenue Growth Outlook

Deep News
·
Sep 20

Novartis Signs Licensing Deal Worth Up to $5.7 Billion with Monte Rosa Therapeutics

Deep News
·
Sep 15

Novartis Shares Fall After Goldman Sachs Downgrade

MT Newswires Live
·
Sep 13

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

Dow Jones
·
Sep 13

Novartis (NVS) was downgraded to a Sell Rating at Goldman Sachs

TIPRANKS
·
Sep 12

Goldman Sachs Downgrades Novartis to Sell From Neutral, Adjusts Price Target to $118 From $119

MT Newswires Live
·
Sep 12

Novartis Cut to Sell From Neutral by Goldman Sachs

Dow Jones
·
Sep 12

Goldman Sachs Downgrades Novartis AG (NVS.US) to "Sell" Amid Generic Competition and Questioned Growth Narrative

Stock News
·
Sep 12

Novartis AG Rises Thursday, Outperforms Market

Dow Jones
·
Sep 12

Top Premarket Gainers

MT Newswires Live
·
Sep 09

Why JPMorgan is warning the Fed rate cut everyone expects could sink stocks

Dow Jones
·
Sep 09